Attendees who purchased access to the 2016 Annual Meeting webcast were sent login information on May 11, 2016.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 53 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 50 51 52 53 presentations: 1 to 25 of 1308
Computational Cancer Epigenomics
Genome-scale analysis of DNA methylation in cancer: Discoveries, challenges, and opportunities
Hui Shen
Van Andel Research Inst., Grand Rapids, MI, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Computational Cancer Epigenomics
Prioritizing non-coding variants in cancer genomes using epigenetic profiles
Peter J. Park
Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Computational Cancer Epigenomics
Modeling cancer gene regulation with public ChIP-seq profiles
X Shirley Liu
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Microbiome and Cancer Immunotherapy
Cancer as a disease of the symbiont/metaorganism
Giorgio Trinchieri
NCI-Frederick, Bethesda, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Microbiome and Cancer Immunotherapy
Impact of commensal microbiota on anti-tumor immunity and immunotherapy efficacy
Leticia Corrales
University of Chicago, Chicago, IL, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Microbiome and Cancer Immunotherapy
Implications of immunogenic commensals in therapy-induced immunosurveillance
Laurence Zitvogel
Gustave Roussy Cancer Center, Villejuif, France
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Microbiome and Cancer Immunotherapy
Therole of intestinal flora in patients undergoing allogeneic hematopoietic stemcell transplantation
Marcel Van Den Brink
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
The Use of Cell-Free DNA (cfDNA) in the Clinical Setting
Pre-analytical considerations and PCR based approaches
Frank Diehl
Sysmex Inostics, Inc., Mundelein, IL, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
The Use of Cell-Free DNA (cfDNA) in the Clinical Setting
NGS based approaches for ctDNA analysis: Laboratory
Davina Gale
Inivata Ltd., Cambridge, United Kingdom
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
The Use of Cell-Free DNA (cfDNA) in the Clinical Setting
NGS based approaches for ctDNA analysis: Bioinformatics
Maximilian Diehn
Stanford University, Stanford, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
The Use of Cell-Free DNA (cfDNA) in the Clinical Setting
ctDNA analysis of structural changes
Mark Sausen
Personal Genome Diagnostics, Baltimore, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Using Tumor Biology to Drive More Effective Sarcoma Therapy
Overview
Christopher T Denny
University of California, Los Angeles, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Using Tumor Biology to Drive More Effective Sarcoma Therapy
New insights into sarcoma metastasis--opportunities for therapeutic intervention
Poul H.B. Sorensen
Univ. of British Columbia, Vancouver, BC, Canada
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Using Tumor Biology to Drive More Effective Sarcoma Therapy
Are we smart enough to cure sarcoma yet? Ewing sarcoma as a paradigm
Stephen L Lessnick
Nationwide Children's Hosp. Ctr. for Childhood Cancer, Columbus, OH, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Using Tumor Biology to Drive More Effective Sarcoma Therapy
Immunotherapies for Sarcoma: Progress and Challenges
Crystal L. Mackall
Stanford Univ. School of Medicine, Stanford, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Breast Cancer Targets in 2016
Introduction
Lisa A. Carey
UNC Lineberger Comp. Cancer Center, Chapel Hill, NC, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Targeted therapy for ESR1 positive breast cancer
Matthew J. Ellis
Baylor College of Medicine Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Targeting HER2/3 in breast cancer: An overview of genomic changes, drug development and clinical trials
Ron Bose
Washington Univ. School of Medicine, Saint Louis, MO, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Targeting DNA repair
James M. Ford
Stanford University, Stanford, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Breast Cancer Targets in 2016
Resistance to P13K inhibitors: A problem or an opportunity?
Maurizio Scaltriti
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Cancer Evolution: One Cell at a Time
An overview of single cell genomics in the cancer field
Nicholas E. Navin
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Cancer Evolution: One Cell at a Time
The many faces of circulating tumor cells
James B Hicks
University of Southern California, Los Angeles, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Cancer Evolution: One Cell at a Time
Clonal dynamics in space and time: Inference of evolutionary properties of cancer
Sohrab Shah
BC Cancer Agency Vancouver Ctr., Vancouver, BC, Canada
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Emerging Targets for the Treatment of Lung Cancer
Resistance to targeted therapies in lung adenocarcinoma
Mark Awad
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
Emerging Targets for the Treatment of Lung Cancer
Emerging targets in lung adenocarcinoma
Eric A. Collisson
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:15 AM-12:15 PM
<< first | < prev page: of 53 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 50 51 52 53 presentations: 1 to 25 of 1308